<DOC>
	<DOCNO>NCT02216565</DOCNO>
	<brief_summary>This trial aim compare two strategy currently use address acute ischemic stroke middle cerebral artery : medical treatment without endovascular treatment one hand , medical treatment plus endovascular treatment hand . The efficiency strategy assess term early neurological clinical recovery . The study focus three particular situation : ( 1 ) tandem internal carotid middle cerebral artery occlusion , ( 2 ) situation patient benefit fibrinolysis high risk haemorrhage , ( 3 ) situation fibrinolysis recommend delay superior 4.5 hour . The hypothesis test medical approach plus endovascular treatment superior medical treatment alone</brief_summary>
	<brief_title>Embolectomy Acute SYlvian Thrombosis Refractory Ineligible Patients ALteplase</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Radiologically proven acute proximal occlusion middle cerebral artery AND one three follow : 1. tandem internal carotid / middle cerebral artery occlusion 2. intravenous thrombolysis contraindicate high risk haemorrhage 3. intravenous thrombolysis possible delay &gt; 4.5 hour Impossibility perform endovascular recanalization within 6h Clinically minor stroke ( NIHSS score 5 baseline ) Extended cerebral infarction Severe comorbidity Life expectancy 3 month stroke Pregnancy breastfeed modify Rankin Score superior 2 stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Endovascular treatment</keyword>
	<keyword>Tandem carotid occlusion</keyword>
	<keyword>Fibrinolysis</keyword>
</DOC>